The Rational Design of a Novel Potent Analogue of the 5′-AMP-Activated Protein Kinase Inhibitor Compound C with Improved Selectivity and Cellular Activity

Citation

Machrouhi, F., Ouhamou, N., Laderoute, K., Calaoagan, J., Bukhtiyarova, M., Ehrlich, P. J., & Klon, A. E. (2010). The rational design of a novel potent analogue of the 5′-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity. Bioorganic & medicinal chemistry letters, 20(22), 6394-6399.

Abstract

We have designed and synthesized analogues of compound C, a non-specific inhibitor of 5′-AMP-activated protein kinase (AMPK), using a computational fragment-based drug design (FBDD) approach. Synthesizing only twenty-seven analogues yielded a compound that was equipotent to compound C in the inhibition of the human AMPK (hAMPK) α2 subunit in the heterotrimeric complex in vitro, exhibited significantly improved selectivity against a subset of relevant kinases, and demonstrated enhanced cellular inhibition of AMPK.

↓ View online

Read more from SRI

  • An arid, rural Nevada landscape

    Can AI help us find valuable minerals?

    SRI’s machine learning-based geospatial analytics platform, already adopted by the USGS, is poised to make waves in the mining industry.

  • Two students in a computer lab

    Building a lab-to-market pipeline for education

    The SRI-led LEARN Network demonstrates how we can get the best evidence-based educational programs to classrooms and students.

  • Code reflected in a man's eyeglasses

    LLM risks from A to Z

    A new paper from SRI and Brazil’s Instituto Eldorado delivers a comprehensive update on the security risks to large language models.